Paroxetine Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 63629-8527

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paroxetine Hydrochloride (NDC 63629-8527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636298527)

Paroxetine Hydrochloride 25 mg Extended-Release Tablets label by Bryant Ranch Prepack. The label shows the strength as 25 mg, dosage form as film-coated extended-release tablets, and package size of 30 tablets. Includes storage instructions and manufacturer details from Kremers Urban Pharmaceuticals, Seymour, IN. NDC 63629-8527-1 is displayed along with the BRP Pharmaceuticals logo.*

FDA Label Image

Formula (Paroxetine Extended Release Tablets Usp 1)

Chemical structure of Paroxetine Hydrochloride is shown, depicting its molecular arrangement with labeled atoms and bonds characteristic of this active ingredient.*

FDA Label Image

Figure 1 (Paroxetine Extended Release Tablets Usp 2)

A chart presenting fold changes with 90% confidence intervals for Cmax and AUC pharmacokinetic parameters of various interacting drugs (Pimozide, Desipramine, Propranolol, Digoxin, Phenytoin) relative to a reference. The x-axis shows change relative to reference on a logarithmic scale from 0.1 to 10.0.*

FDA Label Image

Figure 2 (Paroxetine Extended Release Tablets Usp 3)

A scatter plot graph depicting the pharmacokinetic (PK) interaction of various drugs with Paroxetine Hydrochloride extended-release tablets 25 mg. The graph shows fold change and 90% confidence intervals for Cmax and AUC values for cimetidine, phenobarbital, phenytoin, digoxin, and diazepam relative to a reference baseline.*

FDA Label Image

Figure 3 (Paroxetine Extended Release Tablets Usp 4)

A forest plot chart depicting pharmacokinetic (PK) parameters including Cmax, Cmin, and AUC with fold changes and 90% confidence intervals across populations with renal impairment (mild, moderate, severe), hepatic impairment, elderly age groups (>65 years) at different doses, and gender (males). The x-axis shows change relative to reference values on a logarithmic scale from 0.5 to 50.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.